Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
DE ›
DERMOWAS
Trademark search for:
DERMOWAS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-04-25 — Application filed
2016-06-30 — Sn assigned for sect 66a appl from ib
2016-07-01 — Application filed
2016-07-05 — Application filed
2016-08-10 — Assigned to examiner
2016-08-11 — Final disposition recorded
2016-08-12 — Office action issued
2016-08-12 — Office action issued
2016-08-12 — Office action issued
2016-09-02 — Office action issued
2017-02-10 — Office action issued
2017-02-25 — Assigned to lie
2017-03-01 — Correspondence received in law office
2017-03-01 — Teas/email correspondence entered
2017-04-12 — Assigned to examiner
2017-05-03 — Examiners amendment -written
2017-05-03 — Examiners amendment e-mailed
2017-05-03 — Notification of examiners amendment e-mailed
2017-05-03 — Examiner's amendment entered
2017-05-03 — Approved for pub - principal register
2017-05-09 — Law office publication review completed
2017-05-24 — Notification of notice of publication e-mailed
2017-06-07 — Notice of start of opposition period created, to be sent to ib
2017-06-07 — Notification of possible opposition sent to ib
2017-06-13 — Published for opposition
2017-06-13 — Official gazette publication confirmation e-mailed
2017-06-24 — Notification processed by ib
2017-08-29 — Registered-principal register
2017-10-31 — Teas revoke/app/change addr of atty/dom rep received
2017-10-31 — Attorney/dom.rep.revoked and/or appointed
2017-11-17 — New representative at ib received
2017-11-29 — Final disposition recorded
2017-12-12 — Generic madrid transaction created
2017-12-13 — Generic madrid transaction sent to ib
2018-01-19 — Final disposition recorded
2022-08-29 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2022-09-24 — New representative at ib received
2023-01-24 — Teas change of owner address received
2023-01-24 — Teas revoke/app/change addr of atty/dom rep received
2023-01-24 — Attorney/dom.rep.revoked and/or appointed
2023-01-24 — Teas change of domestic representatives address
2023-01-24 — Teas change of correspondence received
2023-01-24 — Applicant/correspondence changes (non-responsive) entered
2024-03-15 — Cancelled section 71
2024-03-15 — Final status recorded
2024-11-16 — Total invalidation of reg ext protection created
2024-11-29 — Invalidation processed
2024-11-30 — Total invalidation of reg ext protection sent to ib
2024-12-21 — Total invalidation processed by the ib
2025-12-11 — New representative at ib received
Owner Information
Dr. August Wolff GmbH & Co. KG Arzneimittel
DE
Dr. August Wolff GmbH & Co. KG Arzneimittel
DE
Dr. August Wolff GmbH & Co. KG Arzneimittel
DE
Correspondent
Karl M. Zielaznicki Troutman Pepper Hamilton Sanders LLP 600 Peachtree Street, NE, Suite 3000 c/o TM DKT CLK Atlanta, GA 30308
Filing Details
Filing Date:
2016-04-25
Status Date:
2024-03-15
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.